Abstract
Forty critically ill surgical patients with documented infections were studied during their stay in an intensive care unit. Among these patients, 19 developed septic shock and 16 died, 9 of them from septic shock. Interleukin 1 beta (IL-1 beta), tumor necrosis factor (TNF alpha), and interleukin 6 (IL-6) were measured each day and every 1 or 2 hours when septic shock occurred. Although IL-1 beta was never found, TNF alpha was most often observed in the serum at a level under 100 pg/mL except during septic shock. During these acute episodes TNF alpha level reached several hundred pg/mL, but only for a few hours. In contrast, IL-6 was always increased in the serum of acutely ill patients (peak to 500,000 pg/mL). There was a direct correlation between IL-6 peak serum level and TNF alpha peak serum level during septic shock and between IL-6 serum level and temperature or C-reactive protein serum level. Moreover, IL-6 correlated well with APACHE II score, and the mortality rate increased significantly in the group of patients who presented with IL-6 serum level above 1000 pg/mL. Thus, IL-6 appears to be a good marker of severity during bacterial infection.
MeSH Terms
Adult
Aged
Aged, 80 and over
Bacteremia/blood
C-Reactive Protein/analysis
Cause of Death
Critical Illness
Female
Humans
Interleukin-1/analysis
Interleukin-6/analysis
Male
Middle Aged
Severity of Illness Index
Shock/blood
Shock, Septic/blood
Survival Rate
Tumor Necrosis Factor-alpha/analysis
Chemicals
Interleukin-1
Interleukin-6
Tumor Necrosis Factor-alpha
C-Reactive Protein
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Damas P
Department of Anesthesiology, University of Liège, Belgium.
Ledoux D
Nys M
Vrindts Y
De Groote D
Franchimont P
Lamy M
References (29)
29 references, click to expand
-
Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
J Clin Invest. 1988 Jun;81(6):1925-37
PMID: 3384955
-
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
Nature. 1987 Dec 17-23;330(6149):662-4
PMID: 3317066
-
Tumor necrosis factor mediates endotoxic effects in mice.
Infect Immun. 1987 Jul;55(7):1622-5
PMID: 3596805
-
Shock and tissue injury induced by recombinant human cachectin.
Science. 1986 Oct 24;234(4775):470-4
PMID: 3764421
-
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
Science. 1985 Aug 30;229(4716):869-71
PMID: 3895437
-
APACHE II: a severity of disease classification system.
Crit Care Med. 1985 Oct;13(10):818-29
PMID: 3928249
-
A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.
FASEB J. 1991 Mar 1;5(3):338-43
PMID: 1825816
-
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group.
J Infect Dis. 1990 May;161(5):982-7
PMID: 2109023
-
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
Nature. 1990 Dec 6;348(6301):550-2
PMID: 2147233
-
Interleukin-6: an overview.
Annu Rev Immunol. 1990;8:253-78
PMID: 2188664
-
Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality.
Surg Gynecol Obstet. 1990 Jan;170(1):32-8
PMID: 2294627
-
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.
J Infect Dis. 1990 Jan;161(1):79-84
PMID: 2295861
-
Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.
Am Rev Respir Dis. 1990 Jan;141(1):94-7
PMID: 2297191
-
Lymphokines.
N Engl J Med. 1987 Oct 8;317(15):940-5
PMID: 2442611
-
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
J Clin Invest. 1989 Dec;84(6):2008-11
PMID: 2592570
-
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
J Exp Med. 1989 Jan 1;169(1):333-8
PMID: 2783334
-
Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man.
J Immunol. 1989 Apr 1;142(7):2321-4
PMID: 2784459
-
The serum interleukin 6 response to elective surgery.
Lymphokine Res. 1989 Summer;8(2):123-7
PMID: 2786596
-
Increased plasma levels of interleukin-6 in sepsis.
Blood. 1989 Oct;74(5):1704-10
PMID: 2790194
-
Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans.
Crit Care Med. 1989 Oct;17(10):975-8
PMID: 2791581
-
Detection of circulating tumor necrosis factor after endotoxin administration.
N Engl J Med. 1988 Jun 9;318(23):1481-6
PMID: 2835680
-
Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.
Lancet. 1987 Feb 14;1(8529):355-7
PMID: 2880163
-
Serum levels of interleukin-6 and acute phase responses.
Lancet. 1987 Oct 17;2(8564):921
PMID: 2889120
-
Cytokine appearance in human endotoxemia and primate bacteremia.
Surg Gynecol Obstet. 1988 Feb;166(2):147-53
PMID: 3122336
-
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
N Engl J Med. 1988 Aug 18;319(7):397-400
PMID: 3135497
-
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
J Clin Invest. 1988 Apr;81(4):1162-72
PMID: 3258319
-
Functional discrimination between interleukin 6 and interleukin 1.
Eur J Immunol. 1988 Oct;18(10):1535-40
PMID: 3263920
-
Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.
Clin Exp Immunol. 1988 Feb;71(2):314-9
PMID: 3280187
-
Cachectin: more than a tumor necrosis factor.
N Engl J Med. 1987 Feb 12;316(7):379-85
PMID: 3543677